OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
The role of the tumor microenvironment in endocrine therapy resistance in hormone receptor-positive breast cancer
Jie Yuan, Yang Li, Zhi Li, et al.
Frontiers in Endocrinology (2023) Vol. 14
Open Access | Times Cited: 6
Jie Yuan, Yang Li, Zhi Li, et al.
Frontiers in Endocrinology (2023) Vol. 14
Open Access | Times Cited: 6
Showing 6 citing articles:
MAZ-mediated tumor progression and immune evasion in hormone receptor-positive breast cancer: Targeting tumor microenvironment and PCLAF+ subtype-specific therapy
Gaofeng Ni, Yuwei Sun, Hongling Jia, et al.
Translational Oncology (2025) Vol. 52, pp. 102280-102280
Closed Access | Times Cited: 4
Gaofeng Ni, Yuwei Sun, Hongling Jia, et al.
Translational Oncology (2025) Vol. 52, pp. 102280-102280
Closed Access | Times Cited: 4
Tinagl1 restores tamoxifen sensitivity and blocks fibronectin‐induced EMT by simultaneously blocking the EGFR and β1‐integrin/FAK signaling pathways in tamoxifen‐resistant breast cancer cells
Jie Yuan, Yuan Li, Yang Li, et al.
IUBMB Life (2025) Vol. 77, Iss. 1
Closed Access
Jie Yuan, Yuan Li, Yang Li, et al.
IUBMB Life (2025) Vol. 77, Iss. 1
Closed Access
Overexpression of KIF2C amplifies tamoxifen resistance and lung metastasis of breast cancer through PLK1/C-Myc pathway
Rui Tian, Jilin Kong, Hongyan Zang, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2025)
Closed Access
Rui Tian, Jilin Kong, Hongyan Zang, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2025)
Closed Access
Breast Cancer and Tumor Microenvironment: The Crucial Role of Immune Cells
Tânia Moura, Paula Laranjeira, Olga Caramelo, et al.
Current Oncology (2025) Vol. 32, Iss. 3, pp. 143-143
Open Access
Tânia Moura, Paula Laranjeira, Olga Caramelo, et al.
Current Oncology (2025) Vol. 32, Iss. 3, pp. 143-143
Open Access
USP30 Aggravating the Malignant Progression of Breast Cancer and Its Resistance to Tamoxifen by Inhibiting the Ubiquitination of TOMM40
Xinran Gao, J.P. Liu, Baoqing Jia, et al.
Journal of Biochemical and Molecular Toxicology (2025) Vol. 39, Iss. 4
Closed Access
Xinran Gao, J.P. Liu, Baoqing Jia, et al.
Journal of Biochemical and Molecular Toxicology (2025) Vol. 39, Iss. 4
Closed Access
Discovery of oxazine-linked pyrimidine as an inhibitor of breast cancer growth and metastasis by abrogating NF-κB activation
Jie Yuan, Bhanuprakash C. Narasimhachar, Akshay Ravish, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 1
Jie Yuan, Bhanuprakash C. Narasimhachar, Akshay Ravish, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 1
A robust protocol for the systematic collection and expansion of cells from ER+breast cancer tumors and their matching tumor-adjacent tissues
Diana Topolnitska, Camila Lopez Moreno, Alen Paiva, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Diana Topolnitska, Camila Lopez Moreno, Alen Paiva, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
